about
Outpatient and home chemotherapy with novel local control strategies in desmoplastic small round cell tumorIFN regulatory factor 8 sensitizes soft tissue sarcoma cells to death receptor-initiated apoptosis via repression of FLICE-like protein expressionWhole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery.Safety of epidural analgesia in the perioperative care of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.Mesenchymal Stromal Cell Dependent Regression of Pulmonary Metastasis from Ewing's.TNFα cooperates with IFN-γ to repress Bcl-xL expression to sensitize metastatic colon carcinoma cells to TRAIL-mediated apoptosis.TRAIL and doxorubicin combination induces proapoptotic and antiangiogenic effects in soft tissue sarcoma in vivoEvaluation of ototoxicity in patients treated with hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin and sodium thiosulfate.Prognostic significance of tumor response at the end of therapy in group III rhabdomyosarcoma: a report from the children's oncology group.Liposarcoma in children and young adults: a multi-institutional experience.Morphoproteomic profiling of the mammalian target of rapamycin (mTOR) signaling pathway in desmoplastic small round cell tumor (EWS/WT1), Ewing's sarcoma (EWS/FLI1) and Wilms' tumor(WT1)Outcomes of truncal vascular injuries in children.Resection of pulmonary metastases in pediatric patients with Ewing sarcoma improves survival.Impact of tumor viability at second-look procedures performed before completing treatment on the Intergroup Rhabdomyosarcoma Study Group protocol IRS-IV, 1991-1997: a report from the children's oncology group.Surgical management of the incidentally identified ovarian mass.The impact of surgical excision in chest wall rhabdomyosarcoma: a report from the Children's Oncology Group.Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children's Oncology Group.Outcome after surgical resection of recurrent rhabdomyosarcoma.Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric ovarian tumors: a novel treatment approach.Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: a report from the Children's Oncology GroupRhabdomyosarcoma in children.Outcomes in pediatric melanoma: comparing prepubertal to adolescent pediatric patients.The diagnosis and management of desmoplastic small round cell tumor: a review.Recent advances in non-rhabdomyosarcoma soft-tissue sarcomas.Unusual cases: melanomatosis and nephroblastomatosis treated with hyperthermic intraperitoneal chemotherapy.Peritoneal sarcomatosis in pediatric malignancies.Cytoreductive Surgery Followed by Hyperthermic Intraperitoneal Chemotherapy in DSRCT: Progress and Pitfalls.Surgical Feeding Tubes in Pediatric and Adolescent Cancer Patients: A Single-institution Retrospective Review.Evaluating the Impact of Total Intravenous Anesthesia on the Clinical Outcomes and Perioperative NLR and PLR Profiles of Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.Outcomes of chest wall resections in pediatric sarcoma patients.Management of desmoplastic small round cell tumorReduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.Treatment outcomes in pediatric melanoma-Are there benefits to specialized care?
P50
Q21342824-225DD621-B5A1-4C5E-ADED-4935A16BCB2EQ24642376-0E5CB948-6255-475F-B711-B57D755C6C86Q33398380-59C57C49-94F1-4200-A193-9648F4B9BFB6Q33410026-199DD996-143C-4C80-B168-1746EF51B987Q33688230-72CC73A8-D7D2-4552-A3C1-2B91915C09A8Q33802588-8AD8E544-DB07-4FAE-83E9-BC330315BB4AQ34256933-7CC68A65-BADC-4365-9D77-AC1E5108D0EDQ34401647-F764FA8D-1BFB-4C48-B057-81AA5BB21314Q34490071-D603EFFB-D03E-42CC-8E97-1F0B0A1A4427Q34627494-BA98CE3C-9CA9-4BA9-BFBF-8287F5DC8749Q34901968-64BBE621-8ECA-408D-91F9-657AD047305AQ34908328-18B770F4-06F8-425F-A652-5544C1A14A94Q34989361-0E3ADDB4-54BD-46B6-93A7-75FC598B71CFQ35084188-81C9F0AA-177B-4FD9-9C40-013E63CD3A1EQ36104546-95947130-B824-44BC-A561-71D06A254A4AQ36283032-594EB62D-6D8F-4F67-A685-94097BC1FD44Q36284400-9C5BB8A4-580F-4369-A54A-98328AA33963Q36433063-EBEC0019-118C-4568-91B4-EB50B552E86FQ37397505-C694E1C0-B078-47B0-81DB-F29B1500BE81Q37478437-572FCC3B-895E-430A-84F9-F8FF9DE73430Q37485855-8C8C9566-765D-47D0-A0DF-982FD013156FQ37859591-539C1E50-DADB-4B3F-90D6-80FB8B434A1BQ37876163-EFC5C704-E822-4F7A-AD4E-B70D594B278DQ37976208-AD18280F-1F3B-4700-8C59-1F5FD42A6AEAQ38002223-0464F788-8142-4B2A-8D75-96D209EF816FQ38045850-D0B45F64-CAE8-45B1-86FD-44271791C680Q38532596-85EC6A15-2C65-4BEA-9D01-9F12011ACA12Q38662651-9CB8AB73-3F08-45DF-97EB-E105D67F0747Q38774380-E0803146-D482-41C5-9615-7957A778ABA2Q39028317-43695D05-B3D4-4B2E-80B4-4E16C0F1C527Q39036554-555D80D0-18E7-442F-BBB4-4DE160E782A1Q40330433-753AB726-6699-4B6B-AE44-5DDC1A0D2586Q40560126-3168EBB4-D73A-4AC5-9F8F-6403890FC1A7
P50
description
onderzoeker
@nl
name
Andrea Hayes-Jordan
@ast
Andrea Hayes-Jordan
@en
Andrea Hayes-Jordan
@es
type
label
Andrea Hayes-Jordan
@ast
Andrea Hayes-Jordan
@en
Andrea Hayes-Jordan
@es
prefLabel
Andrea Hayes-Jordan
@ast
Andrea Hayes-Jordan
@en
Andrea Hayes-Jordan
@es